The Retinal Biosimilars Market report offers perceptive information regarding drivers, restraints, opportunities, and trends of the Retinal Biosimilars Market. With the use of historic data from (period), the Retinal Biosimilars Market report offers Y-o-Y growth and CAGR until 2026. The insightful data offered in the report makes it an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts and stakeholders that are in search of major industry information in ready-to-access documents with clearly presented tables and graphs.
The global market for Retinal Biosimilars Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2020.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The key manufacturers in this market include
- Novartis (Sandoz)
- Takeda
- Bayer
- Genentech
- Pfenex
- Reliance Life Sciences
- Hetero Drugs
- Intas Pharmaceuticals
- Santo Holding
- Regeneron Pharmaceuticals
On the basis of region, the market is divided into:
- North America (U.S. and Canada)
- Latin America (Brazil, Mexico, Argentina, Columbia, and Rest of Latin America)
- Europe (Germany, the U.K., France, Russia, Italy, and Rest of Europe)
- Asia Pacific (China, Japan, South Korea, India, Southeast Asia, and Rest of Asia Pacific)
- Middle East (Saudi Arabia, UAE, Egypt, and Rest of Middle East)
- Africa (North Africa, Central Africa, and South Africa)
By the product type, the market is primarily segmented into
- Macular Degeneration Drugs
- Diabetic Eye Disease Drugs
- Macular Pucker Drugs
- Others
By the End-user Applications, the market is primarily segmented into
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
We can also provide the customized separate regional or country-level reports, for the following regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Key Highlights of the Report:
- Growth opportunities in the global Retinal Biosimilars Market across major regions during the forecast period.
- Role of emerging markets in the global Retinal Biosimilars Market and the scenario during the 2020-2026.
- Technological and product developments that influence growth of the market.
- New trends and advancements in the global Retinal Biosimilars Market.
- Insight on various product types and their respective market shares in the overall market.
The report offers you perceptive data of the market and highlights its commercial landscape and pivotal factors that propel and hinder the market growth. It also evaluates production processes, major bottlenecks, and solutions to reduce risks associated with R&D and focuses on major growth strategies adopted by leading market players. The report accurately projects the global market value and regional share during the forecast period
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
- Raw material suppliers
- Distributors/traders/wholesalers/suppliers
- Regulatory bodies, including government agencies and NGO
- Commercial research & development (R&D) institutions
- Importers and exporters
- Government organizations, research organizations, and consulting firms
- Trade associations and industry bodies
- End-use industries
Available Customizations
At Worldwide Market Reports we offer tailored researches to help our clients stay ahead in competition.
Table of Contents
Retinal Biosimilars Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Retinal Biosimilars
1.1 Retinal Biosimilars Market Overview
1.1.1 Retinal Biosimilars Product Scope
1.1.2 Market Status and Outlook
1.2 Global Retinal Biosimilars Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Retinal Biosimilars Market by Type
1.3.1 Global Retinal Biosimilars Revenue (Million US$) and Growth Comparison by Type (2014-2025)
1.3.2 Global Retinal Biosimilars Revenue Market Share by Type in 2018
1.3.3 Macular Degeneration Drugs
1.3.4 Diabetic Eye Disease Drugs
1.3.5 Macular Pucker Drugs
1.3.6 Others
1.4 Retinal Biosimilars Market by End Users/Application
1.4.1 Hospital Pharmacies
1.4.2 Retail Pharmacies
1.4.3 Online Pharmacies
2 Global Retinal Biosimilars Competition Analysis by Players
2.1 Global Retinal Biosimilars Market Size (Million US$) by Players (2014-2019)
2.2 Competitive Status
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 Mergers & Acquisitions, Expansion Plans
3 Company (Top Players) Profiles and Key Data
3.1 Novartis (Sandoz)
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Retinal Biosimilars Revenue (Value) (2014-2019)
3.1.5 Recent Developments
3.2 Takeda
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Retinal Biosimilars Revenue (Value) (2014-2019)
3.2.5 Recent Developments
3.3 Bayer
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Retinal Biosimilars Revenue (Value) (2014-2019)
3.3.5 Recent Developments
3.4 Genentech
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Retinal Biosimilars Revenue (Value) (2014-2019)
3.4.5 Recent Developments
3.5 Pfenex
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Retinal Biosimilars Revenue (Value) (2014-2019)
3.5.5 Recent Developments
3.6 Reliance Life Sciences
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Retinal Biosimilars Revenue (Value) (2014-2019)
3.6.5 Recent Developments
3.7 Hetero Drugs
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Retinal Biosimilars Revenue (Value) (2014-2019)
3.7.5 Recent Developments
3.8 Intas Pharmaceuticals
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Retinal Biosimilars Revenue (Value) (2014-2019)
3.8.5 Recent Developments
3.9 Santo Holding
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Retinal Biosimilars Revenue (Value) (2014-2019)
3.9.5 Recent Developments
3.10 Regeneron Pharmaceuticals
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Retinal Biosimilars Revenue (Value) (2014-2019)
3.10.5 Recent Developments
4 Global Retinal Biosimilars Market Size by Type and Application (2014-2019)
4.1 Global Retinal Biosimilars Market Size by Type (2014-2019)
4.2 Global Retinal Biosimilars Market Size by Application (2014-2019)
4.3 Potential Application of Retinal Biosimilars in Future
4.4 Top Consumer/End Users of Retinal Biosimilars
5 North America Retinal Biosimilars Development Status and Outlook
5.1 North America Retinal Biosimilars Market Size (2014-2019)
5.2 North America Retinal Biosimilars Market Size and Market Share by Players (2014-2019)
5.3 North America Retinal Biosimilars Market Size by Application (2014-2019)
6 Europe Retinal Biosimilars Development Status and Outlook
6.1 Europe Retinal Biosimilars Market Size (2014-2019)
6.2 Europe Retinal Biosimilars Market Size and Market Share by Players (2014-2019)
6.3 Europe Retinal Biosimilars Market Size by Application (2014-2019)
7 China Retinal Biosimilars Development Status and Outlook
7.1 China Retinal Biosimilars Market Size (2014-2019)
7.2 China Retinal Biosimilars Market Size and Market Share by Players (2014-2019)
7.3 China Retinal Biosimilars Market Size by Application (2014-2019)
8 Rest of Asia Pacific Retinal Biosimilars Development Status and Outlook
8.1 Rest of Asia Pacific Retinal Biosimilars Market Size (2014-2019)
8.2 Rest of Asia Pacific Retinal Biosimilars Market Size and Market Share by Players (2014-2019)
8.3 Rest of Asia Pacific Retinal Biosimilars Market Size by Application (2014-2019)
9 Central & South America Retinal Biosimilars Development Status and Outlook
9.1 Central & South America Retinal Biosimilars Market Size (2014-2019)
9.2 Central & South America Retinal Biosimilars Market Size and Market Share by Players (2014-2019)
9.3 Central & South America Retinal Biosimilars Market Size by Application (2014-2019)
10 Middle East & Africa Retinal Biosimilars Development Status and Outlook
10.1 Middle East & Africa Retinal Biosimilars Market Size (2014-2019)
10.2 Middle East & Africa Retinal Biosimilars Market Size and Market Share by Players (2014-2019)
10.3 Middle East & Africa Retinal Biosimilars Market Size by Application (2014-2019)
11 Market Forecast by Regions and Application (2019-2025)
11.1 Global Retinal Biosimilars Market Size by Regions (2019-2025)
11.1.1 North America Retinal Biosimilars Revenue and Growth Rate (2019-2025)
11.1.2 Europe Retinal Biosimilars Revenue and Growth Rate (2019-2025)
11.1.3 China Retinal Biosimilars Revenue and Growth Rate (2019-2025)
11.1.4 Rest of Asia Pacific Retinal Biosimilars Revenue and Growth Rate (2019-2025)
11.1.5 Central & South America Retinal Biosimilars Revenue and Growth Rate (2019-2025)
11.1.6 Middle East & Africa Retinal Biosimilars Revenue and Growth Rate (2019-2025)
11.2 Global Retinal Biosimilars Market Size by Application (2019-2025)
11.3 The Market Drivers in Future
12 Retinal Biosimilars Market Dynamics
12.1 Industry Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porters Five Forces Analysis
13 Research Finding /Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
List of Table
List of Tables and Figures
Figure Global Retinal Biosimilars Market Size (Million USD) Status and Outlook (2014-2025)
Table Global Retinal Biosimilars Market Size (Million USD) and Growth Rate by Regions (2014-2025)
Figure Global Retinal Biosimilars Market Share by Regions (2014-2019)
Figure North America Retinal Biosimilars Market Size (Million USD) and Growth Rate (2014-2019)
Figure Europe Retinal Biosimilars Market Size (Million USD) and Growth Rate (2014-2019)
Figure China Retinal Biosimilars Market Size (Million USD) and Growth Rate (2014-2019)
Figure Rest of Asia Pacific Retinal Biosimilars Market Size (Million USD) and Growth Rate (2014-2019)
Figure Central & South America Retinal Biosimilars Market Size (Million USD) and Growth Rate (2014-2019)
Figure Middle East & Africa Retinal Biosimilars Market Size (Million USD) and Growth Rate (2014-2019)
Figure Global Retinal Biosimilars Market Share by Type in 2018 & 2025
Figure Macular Degeneration Drugs Market Size (Million USD) and Growth Rate (2014-2019)
Figure Diabetic Eye Disease Drugs Market Size (Million USD) and Growth Rate (2014-2019)
Figure Macular Pucker Drugs Market Size (Million USD) and Growth Rate (2014-2019)
Figure Others Market Size (Million USD) and Growth Rate (2014-2019)
Table Global Retinal Biosimilars Market Size (Million US$) Comparison by Application (2014-2025)
Figure Global Retinal Biosimilars Market Share by Application in 2018 & 2025
Figure Retinal Biosimilars Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2014-2019)
Figure Retinal Biosimilars Market Size (Million USD) and Growth Rate in Retail Pharmacies (2014-2019)
Figure Retinal Biosimilars Market Size (Million USD) and Growth Rate in Online Pharmacies (2014-2019)
Table Global Retinal Biosimilars Revenue (Million US$) by Players (2014-2019)
Table Global Retinal Biosimilars Revenue Market Share by Players (2014-2019)
Eigure Retinal Biosimilars Market Size Share by Players in 2018
Table Global Retinal Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Global Top 5 Players Retinal Biosimilars Market Share in 2018
Figure Global Top 10 Players Retinal Biosimilars Market Share in 2018
Table Retinal Biosimilars Key Players Product/Service
Table Mergers & Acquisitions, Expansion Plans
Table Novartis (Sandoz) Basic Information List
Table Novartis (Sandoz) Description and Business Overview
Table Novartis (Sandoz) Retinal Biosimilars Products, Services and Solutions
Table Revenue (Million US$) in Retinal Biosimilars Business of Novartis (Sandoz) (2014-2019)
Table Novartis (Sandoz) Retinal Biosimilars Recent Developments
Table Takeda Basic Information List
Table Takeda Description and Business Overview
Table Takeda Retinal Biosimilars Products, Services and Solutions
Table Revenue (Million US$) in Retinal Biosimilars Business of Takeda (2014-2019)
Table Takeda Retinal Biosimilars Recent Developments
Table Bayer Basic Information List
Table Bayer Description and Business Overview
Table Bayer Retinal Biosimilars Products, Services and Solutions
Table Revenue (Million US$) in Retinal Biosimilars Business of Bayer (2014-2019)
Table Bayer Retinal Biosimilars Recent Developments
Table Genentech Basic Information List
Table Genentech Description and Business Overview
Table Genentech Retinal Biosimilars Products, Services and Solutions
Table Revenue (Million US$) in Retinal Biosimilars Business of Genentech (2014-2019)
Table Genentech Retinal Biosimilars Recent Developments
Table Pfenex Basic Information List
Table Pfenex Description and Business Overview
Table Pfenex Retinal Biosimilars Products, Services and Solutions
Table Revenue (Million US$) in Retinal Biosimilars Business of Pfenex (2014-2019)
Table Pfenex Retinal Biosimilars Recent Developments
Table Reliance Life Sciences Basic Information List
Table Reliance Life Sciences Description and Business Overview
Table Reliance Life Sciences Retinal Biosimilars Products, Services and Solutions
Table Revenue (Million US$) in Retinal Biosimilars Business of Reliance Life Sciences (2014-2019)
Table Reliance Life Sciences Retinal Biosimilars Recent Developments
Table Hetero Drugs Basic Information List
Table Hetero Drugs Description and Business Overview
Table Hetero Drugs Retinal Biosimilars Products, Services and Solutions
Table Revenue (Million US$) in Retinal Biosimilars Business of Hetero Drugs (2014-2019)
Table Hetero Drugs Retinal Biosimilars Recent Developments
Table Intas Pharmaceuticals Basic Information List
Table Intas Pharmaceuticals Description and Business Overview
Table Intas Pharmaceuticals Retinal Biosimilars Products, Services and Solutions
Table Revenue (Million US$) in Retinal Biosimilars Business of Intas Pharmaceuticals (2014-2019)
Table Intas Pharmaceuticals Retinal Biosimilars Recent Developments
Table Santo Holding Basic Information List
Table Santo Holding Description and Business Overview
Table Santo Holding Retinal Biosimilars Products, Services and Solutions
Table Revenue (Million US$) in Retinal Biosimilars Business of Santo Holding (2014-2019)
Table Santo Holding Retinal Biosimilars Recent Developments
Table Regeneron Pharmaceuticals Basic Information List
Table Regeneron Pharmaceuticals Description and Business Overview
Table Regeneron Pharmaceuticals Retinal Biosimilars Products, Services and Solutions
Table Revenue (Million US$) in Retinal Biosimilars Business of Regeneron Pharmaceuticals (2014-2019)
Table Regeneron Pharmaceuticals Retinal Biosimilars Recent Developments
Table Global Retinal Biosimilars Market Size by Type (2014-2019) (Million US$)
Figure Global Retinal Biosimilars Revenue Market Share by Type in 2018
Table Global Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Figure Global Retinal Biosimilars Revenue Market by Application in 2018
Table Top Consumer/End Users of Retinal Biosimilars
Figure North America Retinal Biosimilars Market Size and Growth Rate(2014-2019) (Million USD)
Table North America Retinal Biosimilars Market Size by Players (2014-2019)(Million US$)
Figure North America Retinal Biosimilars Market Size Share by Players in 2018
Table North America Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Figure North America Retinal Biosimilars Revenue Market Share by Application (2014-2019)
Figure North America Retinal Biosimilars Market Size Share by Application in 2018
Figure Europe Retinal Biosimilars Market Size and Growth Rate(2014-2019) (Million USD)
Table Europe Retinal Biosimilars Market Size by Players (2014-2019)(Million US$)
Figure Europe Retinal Biosimilars Market Size Share by Players in 2018
Table Europe Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Figure Europe Retinal Biosimilars Revenue Market Share by Application (2014-2019)
Figure Europe Retinal Biosimilars Market Size Share by Application in 2018
Figure China Retinal Biosimilars Market Size and Growth Rate(2014-2019) (Million USD)
Table China Retinal Biosimilars Market Size by Players (2014-2019)(Million US$)
Figure China Retinal Biosimilars Market Size Share by Players in 2018
Table China Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Figure China Retinal Biosimilars Revenue Market Share by Application (2014-2019)
Figure China Retinal Biosimilars Market Size Share by Application in 2018
Figure Rest of Asia Pacific Retinal Biosimilars Market Size and Growth Rate(2014-2019) (Million USD)
Table Rest of Asia Pacific Retinal Biosimilars Market Size by Players (2014-2019)(Million US$)
Figure Rest of Asia Pacific Retinal Biosimilars Market Size Share by Players in 2018
Table Rest of Asia Pacific Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Figure Rest of Asia Pacific Retinal Biosimilars Revenue Market Share by Application (2014-2019)
Figure Rest of Asia Pacific Retinal Biosimilars Market Size Share by Application in 2018
Figure Central & South America Retinal Biosimilars Market Size and Growth Rate(2014-2019) (Million USD)
Table Central & South America Retinal Biosimilars Market Size by Players (2014-2019)(Million US$)
Figure Central & South America Retinal Biosimilars Market Size Share by Players in 2018
Table Central & South America Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Figure Central & South America Retinal Biosimilars Revenue Market Share by Application (2014-2019)
Figure Central & South America Retinal Biosimilars Market Size Share by Application in 2018
Figure Middle East & Africa Retinal Biosimilars Market Size and Growth Rate(2014-2019) (Million USD)
Table Middle East & Africa Retinal Biosimilars Market Size by Players (2014-2019)(Million US$)
Figure Middle East & Africa Retinal Biosimilars Market Size Share by Players in 2018
Table Middle East & Africa Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Figure Middle East & Africa Retinal Biosimilars Revenue Market Share by Application (2014-2019)
Figure Middle East & Africa Retinal Biosimilars Market Size Share by Application in 2018
Figure Global Retinal Biosimilars Market Size and Growth Rate (Value) (2019-2025) (Million US$)
Table Global Retinal Biosimilars Market Size by Regions (2019-2025) (Million US$)
Figure Global Retinal Biosimilars Market Size Share by Regions (2019-2025)
Figure Global Retinal Biosimilars Market Size Share by Regions in 2025
Figure North America Retinal Biosimilars Revenue (Million USD) and Growth Rate (2019-2025)
Figure Europe Retinal Biosimilars Revenue (Million USD) and Growth Rate (2019-2025)
Figure China Retinal Biosimilars Revenue (Million USD) and Growth Rate (2019-2025)
Figure Rest of Asia Pacific Retinal Biosimilars Revenue (Million USD) and Growth Rate (2019-2025)
Figure Central & South America Retinal Biosimilars Revenue (Million USD) and Growth Rate (2019-2025)
Figure Middle East & Africa Retinal Biosimilars Revenue (Million USD) and Growth Rate (2019-2025)
Table Global Retinal Biosimilars Market Size by Application (2019-2025) (Million USD)
Figure Global Retinal Biosimilars Market Size by Application (2019-2025)
Figure Global Retinal Biosimilars Market Size by Application in 2025
Table Global Retinal Biosimilars Market Size by Type (2019-2025) (Million US$)
Figure Global Retinal Biosimilars Market Size by Type (2019-2025)
Figure Global Retinal Biosimilars Market Size by Type in 2025
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure Porter's Five Forces Analysis
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Asia Pacific bioprocess technology market will grow by 15.0% annually with a total addressable market cap of $170.71 billion over 2024-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology...
Europe bioprocess technology market was valued at $6.56 billion in 2023 and will grow by 13.7% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing tech...
North America bioprocess technology market is projected to grow by 13.3% annually in the forecast period and reach $29.68 billion by 2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology s...
Global bioprocess technology market will reach $88.39 billion by 2033, growing by 13.8% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing technologic...
Asia Pacific biopharmaceuticals market will grow by 10.3% annually with a total addressable market cap of $1,776.7 billion over 2024-2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discove...
Europe biopharmaceuticals market was valued at $116.5 billion in 2023 and will grow by 8.6% annually over 2023-2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, growing clinical t...
North America biopharmaceuticals market is projected to grow by 8.4% annually in the forecast period and reach $407.2 billion by 2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, ...
Global biopharmaceuticals market will reach $1,001.1 billion by 2033, growing by 8.8% annually over 2023-2033. The growth is driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, growing cl...
Overview of the Global Biosimilars & Follow-on-Biologics Market:
The report discusses everything a marketer requires before investing in the global Biosimilars & Follow-on-Biologics Market during the forecast period...
The global Retinal Pharmaceuticals market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in t...